Novocure says electric field therapy extends life for pancreatic cancer patients by two months

Novo­cure an­nounced Mon­day morn­ing that its elec­tri­cal fields wear­able de­vice com­bined with chemother­a­py passed a late-stage tri­al in pan­cre­at­ic can­cer, and the biotech now plans …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.